摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-羟基-1-(噻吩-2-基)丙-1-酮 | 86366-54-3

中文名称
3-羟基-1-(噻吩-2-基)丙-1-酮
中文别名
——
英文名称
3-hydroxy-1-(thiophen-2-yl)propan-1-one
英文别名
3-hydroxy-1-thiophen-2-ylpropan-1-one
3-羟基-1-(噻吩-2-基)丙-1-酮化学式
CAS
86366-54-3
化学式
C7H8O2S
mdl
——
分子量
156.205
InChiKey
HBOLQXHOFBSYRL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-羟基-1-(噻吩-2-基)丙-1-酮 在 Cp*IrCl[(S,S)-MsDPEN] potassium formate 作用下, 以 为溶剂, 反应 24.0h, 以72%的产率得到(S)-1-(thiophen-2-yl)propane-1,3-diol
    参考文献:
    名称:
    Organic metal compound and process for preparing optically-active alcohols using the same
    摘要:
    本发明提供了一种在制备具有各种官能团的光学活性醇化合物中有效的非对称还原催化剂,以及使用所述非对称还原催化剂制备光学活性醇化合物的方法。 本发明的有机金属化合物由以下通式(1)表示: 其中R1和R2可以相互相同或不同,并且是烷基、苯基、萘基、环烷基或由R1和R2结合形成的脂肪环环,其中可能含有取代基;R3是氢原子或烷基;Cp是环戊二烯基,可能含有取代基,通过π键与M1结合;X1是卤素原子或氢化物基团;M1是铑或铱;*表示不对称碳。
    公开号:
    US20090062573A1
  • 作为产物:
    描述:
    thienyl vinyl ketone 在 chromium(III) chloride hexahydrate 作用下, 以 乙腈 为溶剂, 反应 24.0h, 以89%的产率得到3-羟基-1-(噻吩-2-基)丙-1-酮
    参考文献:
    名称:
    铬(III)在α,β-不饱和酮上催化的水和醇加成反应,可在水性介质中合成β-羟基和β-烷氧基酮
    摘要:
    开发了一种有效的三价铬氯化物催化的水或醇与α,β-不饱和酮的迈克尔型反应。各种α,β-不饱和酮可与水或醇有效反应,以适度至高收率得到相应的β-羟基酮或β-烷氧基酮,且与各种官能团的相容性极佳。该方法进一步用于制备含有四氢呋喃骨架的合成上有用的化合物。
    DOI:
    10.1021/acs.joc.8b01584
点击查看最新优质反应信息

文献信息

  • ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME
    申请人:Watanabe Masahito
    公开号:US20100261924A1
    公开(公告)日:2010-10-14
    The present invention provides an organic metal compound, a ligand, an asymmetric catalyst, and a process for preparing optically-active alcohols using the asymmetric catalyst. The organic metal compound of the present invention is expressed by the following general formula (1): wherein in general formula (1), R 1 and R 2 are a mutually identical or mutually different, unsubstituted or substituted alkyl group, aryl group, cycloalkyl group, or R 1 and R 2 are bound to form an alicyclic ring, R 3 is a hydrogen atom or an alkyl group, R 4 is a branched alkyl group or an alkyl group that does or does not form a ring by itself, or an unsubstituted or substituted aryl group, or an unsubstituted or substituted heterocyclic group, Ar is an unsubstituted or substituted cyclopentadienyl group that is bound to M via a π bond, or an unsubstituted or substituted benzene, X is a hydride group or an anionic group, M is ruthenium, rhodium or iridium, L is a solvent molecule or a water molecule, l is 1 or 2, m is an integer from 0 to 2, n is 0 or 1, and when n is 0, X does not exist, and * represents asymmetric carbon, wherein R 4 is not a camphor group, a camphor derivative group, an isopropyl group or a phenyl group whenever R 1 and R 2 are both a phenyl group.
    本发明提供一种有机金属化合物、配体、不对称催化剂以及利用该不对称催化剂制备光学活性醇的方法。本发明的有机金属化合物由以下通用式(1)表示: 在通用式(1)中,R1和R2是相互相同或相互不同的未取代或取代的烷基基团、芳基团、环烷基团,或R1和R2结合形成脂环,R3是氢原子或烷基基团,R4是支链烷基基团或自身形成环或不形成环的烷基基团,或未取代或取代的芳基团,或未取代或取代的杂环基团,Ar是通过π键与M结合的未取代或取代的环戊二烯基团,或未取代或取代的苯,X是氢化物基团或阴离子基团,M是钌、铑或铱,L是溶剂分子或水分子,l为1或2,m为0到2的整数,n为0或1,当n为0时,X不存在,*代表不对称碳,其中当R1和R2均为苯基团时,R4不是藿香基团、藿香衍生基团、异丙基团或苯基团。
  • Indium(III)‐Catalyzed Hydration and Hydroalkoxylation of α,β‐Unsaturated Ketones in Aqueous Media
    作者:Jin‐Jin Yun、Man‐Ling Zhi、Wen‐Xiao Shi、Xue‐Qiang Chu、Zhi‐Liang Shen、Teck‐Peng Loh
    DOI:10.1002/adsc.201800301
    日期:2018.7.16
    The hydration of α,β‐unsaturated ketones with water proceeded efficiently in the presence of In(OTf)3 (20 mol%) in aqueous media to afford synthetically versatile β‐hydroxyketones in moderate to good yields with good functional group compatibility. The method also can be extended to the hydroalkoxylation of α,β‐unsaturated ketones with various alcohols for the efficient synthesis of β‐alkoxyketones as
    在水介质中存在In(OTf)3(20 mol%)的情况下,α,β-不饱和酮与水的水合作用有效地进行,从而以中等至良好的产率提供合成通用的β-羟基酮,并具有良好的官能团相容性。该方法还可以扩展到α,β-不饱和酮与各种醇的加氢烷氧基化反应,以有效合成β-烷氧基酮和四氢呋喃衍生物。
  • Chromium(III)-Catalyzed Addition of Water and Alcohol to α,β-Unsaturated Ketones for the Synthesis of β-Hydroxyl and β-Alkoxyl Ketones in Aqueous Media
    作者:Jin-Jin Yun、Xuan-Yu Liu、Wei Deng、Xue-Qiang Chu、Zhi-Liang Shen、Teck-Peng Loh
    DOI:10.1021/acs.joc.8b01584
    日期:2018.9.21
    An efficient chromium(III) chloride-catalyzed Michael-type reaction of water or alcohol with α,β-unsaturated ketones is developed. A variety of α,β-unsaturated ketones effectively reacted with either water or alcohols to give the corresponding β-hydroxyl ketones or β-alkoxyl ketones in modest to high yields with excellent compatibility to various functional groups. The approach was further utilized
    开发了一种有效的三价铬氯化物催化的水或醇与α,β-不饱和酮的迈克尔型反应。各种α,β-不饱和酮可与水或醇有效反应,以适度至高收率得到相应的β-羟基酮或β-烷氧基酮,且与各种官能团的相容性极佳。该方法进一步用于制备含有四氢呋喃骨架的合成上有用的化合物。
  • NOVEL SULFONYL DERIVATIVES
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:EP1104754A1
    公开(公告)日:2001-06-06
    Sulfonyl derivatives represented by the following general formula (I): Q1-Q2-T1-Q3-SO2-QA and drugs containing the same (wherein Q1 is an optionally substituted, saturated or unsaturated, five- or six-membered cyclic hydrocarbon group, a five- or six-membered heterocyclic group, or the like; Q2 is a single band, oxygen, sulfur, C1-C6 alkylene or the like; QA is optionally substituted arylalkenyl, heteroarylalkenyl or the like; and T1 is carbonyl or the like). These compounds have potent FXa-inhibitory effects and promptly exert satisfactory and persistent antithrombotic effects through oral administration, thus being useful as anticoagulant agents little accompanied with side effects.
    以下是通用公式(I)所代表的磺酰衍生物:Q1-Q2-T1-Q3-SO2-QA以及含有这些衍生物的药物(其中Q1是可选择地取代的饱和或不饱和的五元或六元环烃基团,五元或六元杂环基团等;Q2是单键,氧,硫,C1-C6烷基或类似物;QA是可选择地取代的芳基烯烃基团,杂环芳基烯烃基团或类似物;T1是羰基或类似物)。这些化合物具有强大的FXa抑制作用,并通过口服迅速产生令人满意且持久的抗血栓作用,因此可作为几乎不伴随副作用的抗凝血剂。
  • Novel sulfonyl derivatives
    申请人:DAIICHI PHARMACEUTICAL CO., LTD.
    公开号:US20040082611A1
    公开(公告)日:2004-04-29
    Described in the present invention are a sulfonyl derivative represented by the following formula (I): Q 1 -Q 2 -T 1 -Q 3 -SO 2 -Q A (I) [wherein Q 1 represents a saturated or unsaturated 5- or 6-membered cyclic hydrocarbon group, 5- or 6-membered heterocyclic group, dicyclic fused ring or tricyclic fused ring group which may have a substituent; Q 2 represents a single bond, an oxygen atom, a sulfur atom, a linear or branched C 1-6 alkylene group or the like; Q A represents an arylalkenyl group which may have a substituent or a heteroarylalkenyl group which may have a substituent; and T 1 represents a carbonyl group or the like] and a medicament comprising the same. The compound has strong FXa inhibitory action, provides prompt, sufficient and long-lasting anti-thrombus effects when orally administered, and has low side effects and is therefore useful as an excellent anticoagulant.
    本发明描述了一种由以下式(I)表示的磺酰基衍生物: Q1-Q2-T1-Q3-SO2-QA(I) [其中,Q1表示饱和或不饱和的5-或6-环烃基、5-或6-杂环基、二环融合环或三环融合环基,可能具有取代基;Q2表示单键、氧原子、硫原子、线性或支链的C1-6烷基等;QA表示可能具有取代基的芳基烯基或杂芳基烯基;T1表示羰基基团或类似物],以及包含该化合物的药物。该化合物具有强烈的FXa抑制作用,口服后提供快速、充分和持久的抗血栓效果,并且具有低副作用,因此可用作优秀的抗凝剂。
查看更多